Fifth Third Bancorp Grows Stock Holdings in Sotera Health Company $SHC

Fifth Third Bancorp grew its stake in Sotera Health Company (NASDAQ:SHC) by 2,453.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 54,468 shares of the company’s stock after acquiring an additional 52,335 shares during the period. Fifth Third Bancorp’s holdings in Sotera Health were worth $781,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of SHC. Oregon Public Employees Retirement Fund raised its position in Sotera Health by 16.0% during the 1st quarter. Oregon Public Employees Retirement Fund now owns 47,782 shares of the company’s stock valued at $685,000 after purchasing an additional 6,600 shares in the last quarter. Strs Ohio grew its position in shares of Sotera Health by 20.1% during the 1st quarter. Strs Ohio now owns 5,881 shares of the company’s stock worth $84,000 after buying an additional 986 shares in the last quarter. Keybank National Association OH bought a new position in shares of Sotera Health during the 1st quarter worth $179,000. Root Financial Partners LLC increased its stake in shares of Sotera Health by 217.5% during the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock valued at $30,000 after buying an additional 1,455 shares during the period. Finally, Pictet Asset Management Holding SA increased its stake in shares of Sotera Health by 9.5% during the first quarter. Pictet Asset Management Holding SA now owns 32,487 shares of the company’s stock valued at $466,000 after buying an additional 2,827 shares during the period. 91.03% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the stock in a transaction dated Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total value of $193,194,516.17. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 15.36% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on SHC shares. The Goldman Sachs Group began coverage on shares of Sotera Health in a report on Friday, June 5th. They set a “buy” rating and a $20.00 target price on the stock. Barclays increased their target price on Sotera Health from $18.00 to $19.00 and gave the company an “overweight” rating in a research report on Wednesday, June 24th. Piper Sandler reiterated an “overweight” rating and issued a $22.00 price target (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Weiss Ratings raised Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. Finally, UBS Group set a $19.00 price objective on Sotera Health in a research note on Wednesday, June 24th. Eight analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, Sotera Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $20.25.

Sotera Health Price Performance

Shares of SHC opened at $17.24 on Tuesday. The company has a 50 day moving average of $16.69 and a two-hundred day moving average of $16.37. The company has a quick ratio of 2.54, a current ratio of 2.82 and a debt-to-equity ratio of 3.56. Sotera Health Company has a twelve month low of $11.00 and a twelve month high of $19.85. The company has a market cap of $4.92 billion, a price-to-earnings ratio of 42.05 and a beta of 1.76.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.01. The business had revenue of $280.05 million for the quarter, compared to the consensus estimate of $270.78 million. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The business’s quarterly revenue was up 10.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. As a group, analysts predict that Sotera Health Company will post 0.87 earnings per share for the current fiscal year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.